BioSpace News Archive

Pharma, biotech and life sciences companies bolster their executive teams and boards with these Movers & Shakers.

Study to enroll 144 patients with COVID-19 who have progressed to Acute Respiratory Distress and require intensive care with mechanical ventilation

Additional data to be presented validating the SPARE Model for Distant Metastasis Prediction utilizing the Company’s StemPrintER Platform

A seasoned executive with an extensive track record of global leadership in life sciences

Lysogene, a Phase 3 gene therapy platform company targeting central nervous system diseases, announced the upcoming abstract selected for an oral presentation at the virtual 23rd ASGCT Annual Meeting and presentations at the EFGCP and NTSAD family conference.

Innate Pharma SA announced that it will present new data on its lead partnered asset, monalizumab, at the ASCO20 Virtual Scientific Program being held May 29-31, 2020.

Verona Pharma plc announces that it has received written comments from the U.S. Food and Drug Administration in response to its End-of-Phase 2 briefing package for nebulized ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease.

In January 2020, the Company’s Board of Directors decided to explore whether there are conditions for a potential offering of the company’s securities in the United States and a press release with the title “Calliditas submits draft registration statement for the listing of ADSs in the U.S.” was published.

Hutchison China MediTech Limited announces that new and updated analyses on the ongoing studies of savolitinib, surufatinib, and fruquintinib will be presented at the upcoming ASCO20 Virtual Scientific Program, taking place on May 29-31, 2020.

Transparency Market Research has published a new report titled, “Global Motion Preservation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global motion preservation devices market was valued at US$ 611.6 Mn in 2018.